ClinConnect ClinConnect Logo
Search / Trial NCT04632888

The Effect of Telephone Support for Breastfeeding Follow-up on Infantile Colic and Maternal Breastfeeding Self-efficacy

Launched by DOKUZ EYLUL UNIVERSITY · Nov 12, 2020

Trial Information

Current as of July 02, 2025

Completed

Keywords

ClinConnect Summary

Hypothesis; H1: Telephone support for breastfeeding follow-up affects the development of physiological jaundice.

H2: Telephone support for breastfeeding monitoring affects exclusive breastfeeding for the first six months.

H3: Telephone support for breastfeeding follow-up affects infantile colic. H4: Telephone support for breastfeeding follow-up affects maternal breastfeeding self-efficacy.

H5: Telephone support for breastfeeding follow-up affects breastfeeding success of mothers.

Social media communication is planned to be completed at the 36th or older gestational week, who will have h...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Having / had a new birth between the ages of 18-45
  • Having his 1st or 2nd birth
  • Agreeing to participate in the study voluntarily and obtaining consent form
  • Having given birth to a healthy baby above 36 weeks of gestation
  • Planning to breastfeed
  • The baby does not need intensive care and does not develop any postpartum complications
  • The baby does not have a vision and hearing problem, does not have a disease that may prevent breastfeeding
  • The baby does not have a physical and psychological deficit
  • The baby does not have a disease or an anatomical problem that will prevent breastfeeding
  • Mother's ability to continue monitoring on the phone and to have a phone that can provide monitoring and video chat.
  • No blood incompatibility between mother and baby.
  • Exclusion Criteria:
  • Refusal to participate in the study
  • Failure to continue monitoring by phone
  • Mother's illiteracy
  • Development of pathological jaundice in the baby

About Dokuz Eylul University

Dokuz Eylul University is a prominent educational institution located in İzmir, Turkey, recognized for its commitment to advancing medical research and clinical innovation. As a clinical trial sponsor, the university leverages its extensive academic resources and expertise to conduct cutting-edge research aimed at improving patient outcomes. With a focus on interdisciplinary collaboration and adherence to ethical standards, Dokuz Eylul University strives to contribute valuable insights to the medical community while fostering the development of new therapeutic interventions.

Locations

Izmir, , Turkey

Patients applied

0 patients applied

Trial Officials

Gülçin Özalp Gerçeker

Principal Investigator

RN, PhD, Assoc. Prof.

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials